Join the club for FREE to access the whole archive and other member benefits.

Gareth Wakefield

Chief Technical Officer at Xerion Healthcare

Following a BSc and PhD in Physics at the University of Bristol, Dr Wakefield spent five years at the University of Oxford researching novel applications of nanoparticles and quantum semiconductors. Dr Wakefield has over 15 years of experience of developing nanoparticle technology in University of Oxford spin out companies, Oxonica and Oxford Advanced Surfaces. Dr Wakefield co-founded Oxonica in 1999, managing the technical team through development of Optisol sunscreen additives and Envirox diesel catalysts and through to Oxonica’s successful AIM listing in summer 2005.

Visit website: https://xerionhealthcare.co.uk/about/team/#dr-gareth-wakefield

 gareth-wakefield-97223b

See also: Company Xerion Healthcare - Company that works with novel nanoparticle systems

Details last updated 19-Dec-2020

Gareth Wakefield News

Nanotech nurtures unique treatment for inoperable cancers

Nanotech nurtures unique treatment for inoperable cancers

pharmaphorum - 18-Dec-2020

Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer